Press Releases
16 hours ago
MEDVi QUAD Claims Evaluated: Real Online Doctor-Approval ED Medication for Men's Sexual Performance
Indeterminate
GlobeNewswire, Inc.
17 hours ago
EMSense Foot Massager Claims Evaluated: The At-Home Triple Massaging Technology for Healthy Feet Support
Indeterminate
GlobeNewswire, Inc.
17 hours ago
ProstAfense Claims Evaluated: The Strongest Prostate Health Formula for Fast-Acting Results on the Market in 2026
Indeterminate
GlobeNewswire, Inc.
Apr. 4, 2026
Dubai Expands Mental Health Support Through Government and Private Sector Initiatives
Neutral
EIN Presswire
Apr. 4, 2026
Financial Stress Escalates Into a Crucial Public Health Concern, Therapy-Chats.com Analysis Finds
Neutral
EIN Presswire
Apr. 2, 2026
Medicaid Cuts Put Over Four Hundred US Hospitals at Risk of Closure
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Apr. 4, 2026
HiWell Absorfyx Launches Advanced Saw Palmetto Formula for Prostate, Urinary, and Hair Health
Indeterminate
GlobeNewswire, Inc.
Apr. 4, 2026
BienRaíz Launches Premium D3 + K2 Formula for Bone Health and Heart Function
Indeterminate
GlobeNewswire, Inc.
Apr. 3, 2026
Metriq Health Opens in Thousand Oaks, Bringing Physician-Led Hormone Care to Southern California
Neutral
EIN Presswire
Apr. 3, 2026
Overcoming Onychomycosis Claims Evaluated: Blue Heron Health News Nail Fungus Treatment Program is On Sale
Indeterminate
GlobeNewswire, Inc.
Apr. 3, 2026
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire, Inc.
Apr. 1, 2026
Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset
Indeterminate
GlobeNewswire, Inc.
Apr. 3, 2026
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire, Inc.